The Doxorubicin Market is projected to reach USD 1383.75 Million by 2030 at 6.20% CAGR during the forecast period 2022-2030. Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the doxorubicin market are surge...